CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Executive or director change
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 2 of 25 · 494 filings